CAS: 1370651-20-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ensartinib(X-396) REF: 4Z-E-165001CAS: | - - - | To inquire | Mon 13 Jan 25 |
 | Ensartinib REF: TM-T37585CAS: 1370651-20-9 | - - - | 1,721.00 €~2,931.00 € | Mon 13 Jan 25 |
| Ensartinib-13C2-d6 REF: 4Z-E-165002CAS: | - - - | To inquire | Mon 13 Jan 25 |
 | Ensartinib REF: 3D-VEC65120CAS: 1370651-20-9 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-E-165001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ensartinib
CAS:1370651-20-9
Ensartinib (X-396) is a potent and dual ALK/MET inhibitor with IC50s of <0.4 nM and …
Formula:
C26H27Cl2FN6O3
Color and Shape:
Solid
Molecular weight:
561.44
Ref: TM-T37585
| 25mg | 1,721.00 € | ||
| 50mg | 2,250.00 € | ||
| 100mg | 2,931.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-E-165002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Ensartinib
CAS:1370651-20-9
Ensartinib is an investigational drug that is used to treat some types of cancer, such …
Formula:
C26H27Cl2FN6O3
Purity:
Min. 95%
Molecular weight:
561.4 g/mol
Ref: 3D-VEC65120
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
